AcelRx Pharmaceuticals, Inc. announced that Richard F. Afable, M.D., president and CEO of Covenant Health Network, was appointed to the company's board of directors. Guy Nohra, co-founder and managing director of venture capital firm Alta Partners, resigned from the board as of December 10, 2013.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.155 USD | -4.94% | +13.24% | +57.14% |
May. 14 | Transcript : Talphera, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Talphera, Inc. Appoints Dr. Shakil Aslam as Chief Development Officer, Effective May 20, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.14% | 20.65M | |
+11.98% | 9.08B | |
-12.85% | 5.06B | |
+54.35% | 4.85B | |
+1.60% | 3.85B | |
+14.09% | 2.37B | |
-20.85% | 2.36B | |
+24.62% | 2.27B | |
-29.25% | 2.22B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- TLPH Stock
- News Talphera, Inc.
- AcelRx Pharmaceuticals, Inc. Announces Board Changes